Nutra Pharma Corp., a biotechnology holding company that owns rights to intellectual property related to the development of drugs for Multiple Sclerosis and HIV has announced that its President and Chief Executive Officer, Rik J. Deitsch, is currently featured in an on-line interview with CEOcast, Inc. During the interview, Mr. Deitsch outlines the Company's strategy through the next twelve months and discusses other matters relating to Nutra Pharma and its shareholders.
The interview is available at http://www.ceocast.com. To access Mr. Deitsch's interview, click on the "Register Free" banner in the upper right corner of the page. You will be prompted to enter your name, e-mail address, and create a password. This will register you and send you back to CEOcast's home page. At that point, type in Nutra Pharma or its ticker symbol, "NPHC," and you will be directed to the interview.
This press release contains forward-looking statements. The words or phrases "would be," "will allow," "intends to," "will likely result," "are expected to," "will continue," "is anticipated," "estimate," "project," or similar expressions are intended to identify "forward-looking statements." Actual results could differ materially from those projected in Nutra Pharma's ("the Company") business plan. The Company's business is subject to various risks, which are discussed in the Company's filings with the Securities and Exchange Commission ("SEC"). The online interview with CEOcast should not be construed as an indication in any way whatsoever of the value of the Company or its common stock. The Company's filings may be accessed at the SEC's Edgar system at www.sec.gov. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company cautions readers not to place reliance on such statements. Unless otherwise required by applicable law, we do not undertake, and we specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.